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The rising prevalence of diabetes mellitus (DM) worldwide, especially in developing coun-
tries, and the persistence of tuberculosis (TB) as a major public health issue in these same
regions, emphasize the importance of investigating this association. Here, we compared
the clinical profile and disease outcomes of TB patients with or without coincident DM in a
TB reference center in Brazil.
Methods
We performed a retrospective analysis of a TB patient cohort (treatment naïve) of 408 indi-
viduals recruited at a TB primary care center in Brazil between 2004 and 2010. Data on
diagnosis of TB and DM were used to define the groups. The study groups were compared
with regard to TB disease presentation at diagnosis as well as to clinical outcomes such as
cure and mortality rates upon anti-tuberculosis therapy (ATT) initiation. A composite score
utilizing clinical, radiological and microbiological parameters was used to compare TB
severity between the groups.
Results
DM patients were older than non-diabetic TB patients. In addition, diabetic individuals more
frequently presented with cough, night sweats, hemoptysis and malaise than those without
DM. The overall pattern of lung lesions assessed by chest radiographic examination was
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similar between the groups. Compared to non-diabetic patients, those with TB-diabetes
exhibited positive acid-fast bacilli in sputum samples more frequently at diagnosis and at 30
days after ATT initiation. Notably, higher values of the TB severity score were significantly
associated with TB-diabetes comorbidity after adjustment for confounding factors. More-
over, during ATT, diabetic patients required more frequent transfers to TB reference hospi-
tals for complex clinical management. Nevertheless, overall mortality and cure rates were
indistinguishable between the study groups.
Conclusions
These findings reinforce the idea that diabetes negatively impacts pulmonary TB severity.
Our study argues for the systematic screening for DM in TB reference centers in endemic
areas.
Introduction
The association between diabetes mellitus (DM) and tuberculosis (TB) has been known since
the beginning of the 20th century [1]. However, it was only after the recent increase in the bur-
den of type 2 diabetes [2], attributed mainly to the modern lifestyle changes, that the link
between these two diseases was subject to further interest. According to the World Health
Organization (WHO), an estimated 350 million people around the world had diabetes in 2011,
80% of whom were living in developing countries. Notably, it is predicted that global diabetes
prevalence will increase 50% by 2030 with the greatest increase in low and middle income
countries [3]. Despite the decrease of mortality observed in the last two decades, Brazil remains
among the 22 countries responsible for 80% of TB cases worldwide with a death rate of 2.3 per
100 thousand inhabitants, [4]. Scarce data have been reported on the prevalence of DM in Bra-
zil. The prevalence of DM was estimated to be 7.6% in a cross-sectional home survey conducted
from November 1986 to July 1988 in a random sample of 21,847 individuals aged 30–69 years
in nine Brazilian cities [5]. Importantly, a recent study demonstrated that the proportion of
diabetes among TB cases in Brazil increased from 380 cases/100,000 habitants to 6,150/100,000
between 2001 to 2011 [6], highlighting the need for more systematic studies describing epide-
miology and clinical aspects of TBDM comorbidity in the country.
Diabetes is linked to increased risk for certain infectious diseases including TB [1,7]. We
have recently shown that patients with TBDM comorbidity from South India display height-
ened levels of plasma biomarkers of inflammation, tissue remodeling, and oxidative stress; all
of which could be driving increased susceptibility to worse TB-related clinical outcomes [8].
Understanding TBDM interaction in Brazil could provide a basis in evidence for enhanced
clinical management of patients with this dual burden and have a positive impact on public
health.
The present study compares the clinical presentation profile and outcomes of TB in diabetic
and non-diabetic patients recruited at a TB primary care reference center in a highly TB
endemic area in Brazil [9]. The results indicate that diabetes may exacerbate TB disease
severity.
Tuberculosis-Diabetes Comorbidity in Brazil
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Methods
Ethics statement
All clinical investigations were conducted according to the principles expressed in the Declara-
tion of Helsinki. The study was approved by the Ethics Committee of the Maternidade Clí-
mério de Oliveira, Federal University of Bahia (protocol number: 037/2011, Ethics committee
approval number: 034/11). All materials given to the research team were de-identified.
Study site
The study was performed at the Instituto Brasileiro para a Investigação da Tuberculose (IBIT,
Brazilian Institute for TB investigation), which is a philanthropic TB outpatient clinic in Salva-
dor, Brazil. This institute is part of the Brazilian National TB control program and has been
providing free TB diagnosis, clinical care, anti-microbial chemotherapy and social support ser-
vices to TB patients since its foundation on 1937. IBIT serves as a reference center for TB pri-
mary care and annually treats 10–15% TB cases of the city of Salvador, Bahia [10]. Diagnosis of
TB at IBIT follows the guidelines of the Brazilian Society of Pulmonology and Tisiology [11],
which is similar to WHO recommendations [12]. ATT is also performed following the Brazil-
ian national guidelines [11]. All patients who receive a TB diagnosis at IBIT are included
sequentially in a registry and followed monthly until cure or transfer to tertiary care centers
(TB reference hospitals), which occurs in the case of medical complications that require more
complex clinical management. In the circumstance of a patient being transferred to tertiary
centers, follow-up information, including those directly related to death, treatment failure and/
or relapse, were electronically available for the study through a county surveillance system.
During each patient visit, specialized physicians complete clinical report forms with informa-
tion on socio-economic status, epidemiological and clinical features. Comorbidities such as
HIV infection, cancer, hypertension and metabolic diseases are actively screened at routine
patient visits. Radiological evaluation is also systematically performed in all patients. IBIT’s
nurses trained in public health and data management input all the information collected during
the patient visits into IBIT’s electronic databank, which is used to assist the health personnel
involved with patient care. At the time of this study, all identifying patient information was
either coded or redacted by IBIT.
Study design
We performed a retrospective analysis of medical records including all TB cases seen at IBIT
from 2004 to 2010, a total of 2,189 individuals. In the patient datasets, we searched for those
who, at the time of TB diagnosis (treatment naïve), had DM diagnosis by either self-report or
registry of DM diagnosis criteria following the American Diabetes Association guidelines [13]
in the medical reports. We identified 135 individuals with TB-diabetes. Moreover, we sampled
TB patients who did not have diagnosis for DM in the clinical report forms. We systematically
assigned individuals enrolled in IBIT’s registry book immediately prior to or after a TBDM
individual was enrolled. These individuals are identified in this study as non-DM TB patients.
In the case that a non-DM TB individual was non-eligible a person listed immediately prior or
later was selected instead. Following these criteria, we selected 273 non-DM TB individuals.
Exclusion criteria for this study were age under 18-years old and incomplete medical reports.
In order to minimize information bias, the data used in this particular study were collected uti-
lizing standardized questionnaires, which were filled by two of the authors (C.A.M.O. and L.S.
H.).
Tuberculosis-Diabetes Comorbidity in Brazil
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TB severity score
In order to estimate TB disease severity in our study population, we used a modified version of
a previously published clinical score [14]. In this scoring system, one point was given for the
presence of each major TB-related symptom (cough, fever, weigh loss, night sweats, anorexia,
hemoptysis and malaise). The total score can range from zero (no symptoms) to 7 (all symp-
toms) [14]. In this context, patients presenting with a score value4 were classified as having
severe TB. In addition, we built a composite score combining the same TB symptoms (cough,
fever, weigh loss, night sweats, anorexia, hemoptysis and malaise), one radiographic finding in
posteroanterior chest x-ray (presence of cavitary lesion) assessed by an expert physician in the
clinic (E.M.N.) and presence of acid-fast bacilli (AFB) positive sputum smear at TB diagnosis.
To produce the score value, one point was given for the presence of each symptom, cavitary
TB, and positive AFB smear. Thus, the total score could range from zero (no symptoms
detected, no cavitary lesion and AFB negative sputum smear at diagnosis) to 9 (all symptoms,
presence of cavity by chest radiography and AFB positive smear). Individuals were further cate-
gorized as having mild TB (scores from zero to 5) or severe TB (score>5).
Data analysis
The median values with interquartile ranges (IQR) were used as measures of central tendency.
The Fisher’s and chi-square tests were used to compare nominal variables between diabetic
and non-diabetic individuals with TB. Continuous variables were compared between the study
groups using the Mann-Whitney test. Logistic regression analyses adjusted for age and gender
were performed to assess the odds ratios (OR) of the associations between the TB severity score
and TB-diabetes comorbidity. Multinomial logistic regression analysis adjusted for age and
gender was used to assess the odds ratios of the associations between TB-diabetes comorbidity
and transfer to a tertiary health care center. A p-value below 0.05 was considered statistically
significant. The statistical analyses were performed using SPSS 20.0 (IBM statistics), Graphpad
Prism 6.0 (GraphPad Software, San Diego, CA) and JMP 10.0 (SAS, Cary, NC, USA).
Results
By retrospectively assessing clinical report forms from our TB cohort, we detected 135 diabetic
patients (TBDM) and selected 273 non-DM individuals. Gender distribution was similar
between the groups (male gender = 64.4% in TB vs. 54.8% in TBDM; P = 0.11). TBDM individ-
uals were on average older than non-diabetics (median age: 37.9 yrs., IQR: 27.3–49.6 vs. 52 yrs.,
IQR: 45.9–60, P<0.001; Table 1). In addition, both groups displayed comparable BMI values
(median BMI = 19.68 kg/m2; IQR: 17.16–21.40 vs. 21.36 kg/m2; IQR: 20.04–24.95; P = 0.43).
Moreover, TBDM and non-DM TB patients did not differ with regard to lifestyle habits
(chronic alcoholism, smoking and use of illicit drugs), prevalence of HIV and/or cancer comor-
bidities, and prevalence of tuberculin skin test (TST) positivity (Table 1).
We next compared the groups with regard to clinical presentation of TB disease. Interest-
ingly, only one patient with DM (0.7%) presented with extra-pulmonary TB (pericardial TB),
compared to 19 (7%) in non-DM TB patients (Table 1). Among non-DM TB patients, the
extra-pulmonary sites were pleura (n = 19, 67.8%), lymph nodes (n = 7, 25.0%), larynges
(n = 1, 3.6%) and eyes (n = 1, 3.6%). Symptoms that are classically associated with TB (cough,
night sweats, hemoptysis, and malaise) [4,14] were more frequent in TBDM patients (Fig 1A
and Table 2). Radiological evaluation revealed that non-DM TB patients exhibited similar dis-
tribution of lung lesions and prevalence of cavitation than those with TBDM comorbidity (Fig
1B). In the entire study population, cavitary TB was associated with higher frequency of
Tuberculosis-Diabetes Comorbidity in Brazil
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individuals presenting with positive AFB smear samples (49.9% of AFB+ in cavitary TB vs.
23.8% in non-cavitary disease, p<0.0001; Fig 1C).
Smear positive TB cases are thought to transmitM. tuberculosis more efficiently than those
with smear negative screening [15]. In addition, previous studies have indicated that smear
positive TB patients exhibit higher levels of acute phase protein in blood as well as bilateral
lung lesions [16], indicating that presence ofM. tuberculosis in sputum may be associated with
more severe forms of TB disease. In our study, the proportion of patients with an initial posi-
tive AFB sputum smear was greater amongst the TBDM group (84.7% vs. 69.1%, p<0.001; Fig
1D). Notably, after 30 days of ATT initiation, positive smears were more frequent in TBDM
than non-DM TB individuals (40.9% vs. 14.7%; p = 0.01; Table 2). We next asked whether
presence of cavitary lung lesions was associated with increased bacterial loads of sputum sam-
ples in both TBDM and non-DM pulmonary TB patients. Non-diabetic individuals presenting
with cavitary TB exhibited increased frequency of positive AFB smear detection and also higher
bacterial loads (e.g. AFB3+) compared to non-diabetic individuals without lung cavities
(chi-square P<0.0001; Fig 1E). Intriguingly, we observed that in TBDM patients, cavitary TB
was not associated with further increases in bacterial loads assessed by sputum AFB stain (chi-
square p = 0.9439; Fig 1E). These observations suggest that at the time of TB diagnosis, DM
patients might have greater lung bacterial loads than non-DM or that DM causes a unique,
non-cavitary pathology that enbalesM. tuberculosis to reach the airways.
Clinical scores designed to infer TB disease severity have been previously reported
[14,17,18]. Here, we composed a score adapted from previous work [14], utilizing clinical
symptoms shown in Fig 1A. In addition, we created a new score considering also radiological
(presence of cavitation) and microbiological (AFB smear positivity) information at time of
diagnosis. When the purely clinical score is applied, we failed to observe differences in the val-
ues between TB and TBDM patients (Fig 2A). On the other hand, analysis using the composite
score with radiological and microbiological data revealed that TBDM individuals displayed
higher values than non-DM TB patients (Fig 2A). We further categorized individuals into
groups of mild and severe TB based on the prevalence of symptoms, lung cavitation and smear
positivity. Once again, stratification of patients using of the clinical score alone could not
Table 1. Characteristics of the study participants.
Characteristic (TB / TBDM) TB TBDM P-value
Male–n (%) 273 / 135 173 (63.4) 74 (54.8) 0.11
Median age–y (IQR) 273 / 135 37.9 (27.3–49.6) 52 (45.9–60) <0.001
Median BMI–kg/m2 (IQR) 68 / 40 19.7 (17.2–21.4) 21.4 (20–24.9) 0.43
Chronic alcoholism–n(%) 263 / 128 53 (20.2) 19 (14.8) 0.21
Smoking–n(%) 265 / 134 114 (43.0) 65 (48.5) 0.33
Illicit drugs use–n(%) 267 / 132 6 (5.9) 3 (2.2) 0.13
HIV/AIDS–n(%) 269 / 132 2 (0.7) 0 (0) 0.32
Cancer–n(%) 269 / 132 4 (1.5) 1 (0.8) 0.54
TST result–n (%) 189 / 85 0.96
< 5 mm 10 (5.3) 5 (5.9)
5 to 10 mm 10 (5.3) 4 (4.7)
 10 mm 169 (89.4) 76 (89.4)
Frequency data were compared using the exact Fisher’s test and Chi-square (for TST result) whereas continuous variables (age and BMI) were compared
using the Mann-Whitney test. The TB / TBDM column shows number of patients in each study group that information was available for. BMI, Body Mass
Index; DM, Diabetes Mellitus; IQR, Interquartile range; TB, Tuberculosis; TST, tuberculin skin test.
doi:10.1371/journal.pone.0146876.t001
Tuberculosis-Diabetes Comorbidity in Brazil
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discriminate mild (<4 points) from severe TB (4 points) between TB and TBDM (Fig 2B).
Using the expanded composite score, TBDM comorbidity was associated with increased fre-
quency of patients presenting with severe disease (Fig 2B). Importantly, higher values of the
composite score were associated with occurrence of TBDM even after adjustments for potential
confounding factors, such as age and gender (Fig 2C). These findings argue that DM affects TB
clinical presentation, possibly driving more severe forms of this disease. In addition, we con-
clude that our composite score may be better discriminator of TB disease severity in TBDM
than purely clinical scores.
Fig 1. Clinical, radiographic andmicrobiological profiles of patients with TB-diabetes comorbidity. (A) Prevalence of indicated TB-related symptoms
were compared between patients with TB-diabetes (TBDM) comorbidity and non-diabetics (TB). (B) Frequency of lung lesions identified by chest
radiography was compared between the study groups. Prevalence of AFB positive smear in TB patients with or without lung cavitary lesions (C) and in
diabetic or non-diabetic patients (D) is shown. (E) AFB distribution profile in patients with or without cavitary lung lesion from either TB without DM or in TBDM
patients. The Fisher’s exact test was used to assess statistical significance in in (A-D) whereas the chi-square test was used to compare data in (E).
doi:10.1371/journal.pone.0146876.g001
Tuberculosis-Diabetes Comorbidity in Brazil
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Both patient groups displayed similar cure rates with antimicrobial therapy (TB: 93.7% of
cure vs. TBDM: 85.5%, p = 0.72; Table 3). Nevertheless, TBDM patients experienced
Table 2. Clinical and laboratory characterization of the study participants.
Variables–n (%) (TB / TBDM) TB TBDM P-value
Positive sputum smear
Pre-ATT 269 / 131 186 (69.1) 111 (84.7) <0.0001
30 days of ATT 75 / 44 11 (14.7) 18 (40.9) 0.01
60 days of ATT 118 / 74 13 (10.9) 6 (8.1) 0.71
180 days of ATT 214 / 105 8 (3.8) 2 (2) 0.68
Positive culture pre-ATT 193 / 81 164 (85) 73 (90.1) 0.27
Extrapulmonary TB 273 / 135 19 (7) 1 (0.7) <0.0001
Frequency data were compared using the exact Fisher’s test. DM, Diabetes Mellitus; TB, Tuberculosis. The TB / TBDM column shows number of patients
in each study group that information was available for.
doi:10.1371/journal.pone.0146876.t002
Fig 2. TB-diabetes comorbidity is associated with increased TB severity assessed by a composite score. (A) The differences in median values (and
IQR) between clinical score (left panel; only symptoms were considered) and composite score (right panel; symptoms, presence of cavitation and AFB+ in
smear samples were considered) obtained in TB and TBDM groups were compared using the Mann-Whitney test. (B) Patients were further categorized in
mild TB (<4points) or severe TB (4 points) using the clinical score (left panel). A similar stratification in mild TB (5 points) or severe TB (>5 points) was
performed using the composite score. The frequency profile of TB and TBDM patients classified into severity categories was compared using the Fisher’s
exact test. (C) Linear regression analysis were compared for clinical and composite score adjusted for age and gender was utilized to determine the
association between increases of 1 point in the severity scores and presence of TB-diabetes comorbidity (OR, Odds ratio; 95%CI, 95% confidence interval).
doi:10.1371/journal.pone.0146876.g002
Tuberculosis-Diabetes Comorbidity in Brazil
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unfavorable events more frequently after treatment initiation (Fig 3A), which were defined
here as death or transfer to TB reference hospitals for more complex health care. Frequency of
these events was higher TBDM patients presenting with severe disease (Fig 3B). TBDM
patients were transferred more frequently to TB reference hospitals (Fig 3C) but exhibited sim-
ilar mortality rates to non-DM TB individuals (Fig 3C). Of note, all patients with extrapulmon-
ary TB and the two HIV-infected individuals included in the present study did not exhibit
unfavorable events (all patients cured from TB after treatment and did not required transfer to
a tertiary center). Multinomial logistic regression analysis adjusted for age and gender con-
firmed the association between occurrence of TBDM comorbidity and the need of transfer to
Table 3. Clinical outcomes of the study participants upon anti-tuberculosis treatment initiation.
Outcome TB (n = 244) TBDM (n = 128) P-value
Cure 236 (93.7) 112 (85.5) 0.72
Death 5 (2) 4 (3.1) 0.44
Transfer* 3 (1.1) 12 (9.2) <0.0001
*Transfer occurred due to uncontrollable disease in the clinic. DM, Diabetes Mellitus; TB, Tuberculosis.
doi:10.1371/journal.pone.0146876.t003
Fig 3. TB-diabetes comorbidity is associated with higher frequency of patient transfer to tertiary health care centers. (A) Frequencies of total
undesirable events upon ATT initiation (death and transference to tertiary health care centers) in patients with TB or TBDM. (B) Frequencies of total
undesirable events upon ATT initiation between patients with TB or TBDMwith severe TB disease according to a composite score. (C) Frequency of death or
transfer to tertiary health care centers in TB and TBDM patients. (D) Multinomial logistic regression analysis adjusted for age and gender was used to test
association between TBDM comorbidity and the transfer to tertiary health care centers (OR, Odds ratio; 95%CI, 95% confidence interval). In (A) and (C), data
were compared using the Fisher’s exact test. In (B), data were compared using the chi-square test.
doi:10.1371/journal.pone.0146876.g003
Tuberculosis-Diabetes Comorbidity in Brazil
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tertiary care centers (Fig 3D). These results reinforce the idea that coincident TBDM is associ-
ated with more severe TB presentation.
Discussion
Understanding the impact of DM on TB susceptibility in countries that suffer from the dual
burden of these diseases will be key to ushering in focused control strategies adapted to local
epidemiological trends. The present study describes clinical, radiographic and microbiological
features of individuals with TBDM comorbidity compared to non-DM TB patients recruited at
a tuberculosis primary care reference center in Brazil, which displays one of the highest treat-
ment-driven TB cure rates in the country [10].
The prevalence of non-communicable diseases, including DM, increases with age [19,20].
Our finding that TBDM patients were on average older than non-diabetic TB individuals
reflects at pattern. According to WHO data, there is a higher prevalence of TB in young adults,
especially males [21]. The association between gender and DM seems to be more complex as
differences in lifestyle may cause changes in the risk of developing DM, influencing the preva-
lence of this disease in women and men. We found that a majority of the pulmonary TB popu-
lation evaluated herein were men; however we could not detect differences in gender
distribution between TBDM and non-DM TB cases. More importantly the combined effects of
age, gender, and additional risk factors for DM, such as obesity, may lead to differential suscep-
tibility for development of symptomatic DM. In the present study the non-DM TB population
had BMI values within the normal range (>18.5 Kg/m2) and although TBDM individuals
exhibited slightly higher values than non-DM, this difference was not statistically significant.
Our outpatient clinic center is designed to provide primary TB care and thus the patient popu-
lation may not have presented with advanced TB-driven consumption syndrome, which would
possibly explain why most of the individuals had BMI within the normal limits.
There are several indications that clinical presentation of TB disease is exacerbated in indi-
viduals with poor glycemic control [22,23]. In addition, glycemic control is thought to influ-
ence radiographic manifestation of pulmonary TB in patients with DM [23]. In agreement
with these studies, we found that compared to non-DM TB individuals TBDM patients more
frequently exhibited symptoms classically associated with pulmonaryM. tuberculosis infection
including cough, night sweats, hemoptysis and malaise. DM has been associated with increased
frequency of atypical radiological findings as well and cavitary TB [24–26]. Intriguingly, the
study groups assessed here did not differ in terms of radiographic localization of lung lesions
or the presence of cavitation, suggesting that the impact of DM on TB-associated lung tissue
destruction in our patient population was subtle. The reasons behind this discrepancy may
involve differences in the populations studied and/or primary care vs. hospital-based settings.
Nevertheless, we observed that TBDM was associated with higher frequency of AFB positive
sputum smear samples at the time of diagnosis and remained increased up to 30 days after
ATT initiation. However, these differences were no longer observed at later time points (day 60
and 180) after treatment initiation. If our results showing that TBDM is associated with more
AFB+ at diagnosis and delayed sputum conversion are validated in future studies, then DM
might be disproportionately contributing to transmission within a community, making this
condition a problem for TB control across the whole population and not only the TB cases.
We also noticed that presence of cavitation was associated with AFB positivity in sputum
smears regardless of DM status. We performed a further sub-analysis stratifying the clinical
groups per AFB sputum grade and presence of cavitation in chest X-rays. As expected in non-
DM TB individuals, the frequency of higher AFB sputum grades was increased in individuals
with lung cavitation compared to those without pulmonary lesions. Strikingly, in the DM
Tuberculosis-Diabetes Comorbidity in Brazil
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subpopulation, presence of cavities was no longer associated with higher AFB smear grades,
indicating that this type of lung lesion is not a predisposing factor driving higherM. tuberculo-
sis loads observed in diabetes. Moreover, our findings indicate that the pathophysiology of TB
in the context of DMmay be restricted to the lungs, as we observed a significantly lower preva-
lence of extrapulmonary TB cases in TBDM patients compared to non-diabetics. Decreased
frequency of extrapulmonary TB in diabetic patients has been previously reported in studies
from India [27,28] and our study reinforces this idea also in a Brazilian cohort. This phenome-
non is the opposite of what occurs in HIV-TB co-infected patients and patients treated with
TNF inhibitors, where extrapulmonary TB is disproportionally increased [29,30]. The mecha-
nisms underlying the discrepancies reported here involving an apparent restriction of suscepti-
bility to pulmonary TB, increasedM. tuberculosis loads and cavitary lesion formation in
TB-DM comorbidity deserve further investigation.
Clinical scores are useful tools to systematically assess TB severity. Here, we adapted a previ-
ously published clinical score [14] and extended its composition to include radiographic (pres-
ence of lung cavitation on the chest X-ray) and microbiological (presence of AFB positive
sputum smear) characteristics at the diagnosis (pre-ATT). We speculate that the severity score
proposed here increases sensitivity to detect differences caused by the impact of DM on TB
because it incorporates variables linked to TB transmissibility (cavitary lesion and AFB positive
smear), which should be considered in public health policy. We found that TBDM individuals
display higher TB severity assessed by this composite score (which was not detected when only
a clinical score was used), further highlighting that the detrimental association between DM
and TB.
Several studies have demonstrated that coincident DM increases the risk of TB treatment
failure, death, and an overall higher frequency of adverse events [23,31–33], including in Brazil
[6]. Our findings showing that clinical management of TBDM individuals required a greater
number of patient transfers to tertiary care centers, implies worse clinical prognosis in TBDM.
This scenario, together with the lack of efforts from the Brazilian health authorities to provide
special care for management of TBDM cases, could amplify the cost of public health care. A
recent systematic review has pointed out the urgent need of increased attention to treatment of
TB in people with DM [23]. This may include routine testing of suspected DM, improved gly-
caemia control and increased clinical and therapeutic monitoring.
Although our results showing increased TB severity in diabetic individuals are in agreement
with several other studies [7,32–34], this finding has not been universal. Some studies have
shown that clinical characteristics of TB do not significantly differ between DM and non-DM
patients (reviewed in [35]). Additional systematic analyses of studies from different countries
and diverse epidemiological settings are necessary to better delineate the interaction between
TB and DM worldwide.
The results presented here are subject to common limitations of retrospective studies with
regard to the documentation of diagnosis and conditions. Particularly concerning the diagnosis
of DM, our criteria were self-disclosure of the condition or laboratory results consistent with
the DM diagnosis following the American Diabetes Association criteria [18]. It is possible that
some diabetic patients were not identified at the time of TB diagnosis because of an incomplete
investigation. Furthermore, we used AFB grade to infer bacterial loads but this parameter is
less accurate than month 2 conversion or time to culture positivity. We did not have systematic
documentation of culture conversion in the clinical reports assessed in the present study. We
also did not have data concerning the status of glycemic control in diabetic patients, which
could affect the impact of DM in TB presentation. We did not find differences in the classical
outcomes systematically examined by some other studies such as death, relapse or reinfection,
possibly due to characteristics of the patients recruited at our primary care reference center.
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Finally, in our cohort, the number of unfavorable events was small, which may reflect the high
cure rates (90%) documented in our institution [10]. A prospective validation study to fur-
ther evaluate the association of these two diseases in the current epidemiological setting is
therefore warranted.
Conclusions
The present study performed in a primary TB care reference center in Brazil, reinforces the
argument that DM negatively impacts the TB clinical profile. Active DM detection in TB refer-
ence centers in endemic countries requires systematic implementation to identify population
at higher risk of adverse events after ATT initiation (such as transfer to tertiary centers) and
potentially reduce the cost of patient care and TB transmission. Our findings also raise the
necessity of a greater investigation and control of DM in the general population of TB endemic
countries.
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